All In Biotech

Drug Trial Radar · NCT05662241

A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With IgG4-Related Disease (INDIGO)

Last checked: Nov 19, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 194 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

194

Actual

Start

Jan 9, 2023

Primary completion

Nov 13, 2025

Study completion Feb 15, 2029

Sponsor

Lead sponsor
Zenas BioPharma (USA), LLCIndustry
Sponsor type
Industry
Collaborators
Bristol-Myers Squibb
First posted
Dec 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to examine the efficacy and safety of obexelimab for the prevention of flare of IgG4-related disease (IgG4-RD)

Conditions

  • IgG4 Related Disease

Interventions

  • ObexelimabDrug

    Obexelimab is a monoclonal antibody that co-engages CD19 and FcγRIIb to inhibit B cell activity

  • PlaceboOther

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary outcome measureTime frame: Randomization to Week 52

Locations

65 sites in 15 countries. Site status is shown where the registry gives one.

  • Stanford Medicine

    Stanford, California

  • GI PROS Research - Dedicated Research Facility

    Naples, Florida

  • Emory Univeristy

    Atlanta, Georgia

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina

  • Artus Health Centre

    Vancouver, British Columbia, Canada

  • Center for Clinical Research (Nova Scotia Health)

    Halifax, Nova Scotia, Canada

  • Centre Hospitalier Universitaire de Sherbrooke CHUS

    Sherbrooke, Quebec, Canada

  • Chinese PLA General Hospital

    Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, China

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology

    Wuhai, Hubei, China

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China

  • Renji Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • Hôpital Beaujon

    Paris, France

  • Hôpital de la Pitié Salpétrière

    Paris, France

  • Haut-Lévèque Hospital Usn Building South Hospital Group

    Pessac, Bordeaux, France

  • Hôpitaux Universitaires de Marseille Timone

    Saint-Pierre, Marseille, France

  • Universitätsklinikum Ulm

    Ulm, Germany

  • LMU Klinikum der Universität München

    München, Bavaria, Germany

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    Brescia, Italy

  • Azienda Ospedaliera Universitaria Meyer Istituto di Ricovero e Cura a Carattere Scientifico

    Florence, Italy

  • Ospedale San Raffaele S.r.l. - PPDS

    Milan, Italy

  • University of Verona

    Verona, Italy

  • Ospedale San Giovanni Bosco

    Turin, Piedmont, Italy

  • Kansai Medical University Hospital

    Hirakata, Japan

  • Hiroshima University Hospital

    Hiroshima, Japan

  • St. Marianna University Hospital

    Kawasaki, Japan

  • Tokyo Medical Center Hospital

    Meguro City, Japan

  • Nagaoka Red Cross Hospital

    Nagaoka, Japan

  • Nagasaki University Hospital

    Nagasaki, Japan

  • Kita-Harima Medical Center

    Ono, Japan

  • Tazuke Kofukai Medical Research Institute Kitano Hospital

    Osaka, Japan

  • Sapporo Medical University Hospital

    Sapporo, Japan

  • Fujita Health University Hospital

    Shinjuku-Ku, Japan

  • Hospital of University of Occupational and Environmental Health

    Kitakyushu, Fukuoka, Japan

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.